Evidence map›Paper›PMID 34093573›Full record

ArticleFrontiers in immunology2021

Human Microglia Extensively Reconstitute in Humanized-BLT Mice With Human Interleukin-34 Transgene and Support HIV-1 Brain Infection.

Jianshui Zhang, Saroj Chandra Lohani, Yilun Cheng, Tao Wang, Lili Guo, Woong-Ki Kim, Santhi Gorantla, Qingsheng Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Humanized immune system animal models and their recent applications.Animal models and experimental medicine · 2026
    Review
  3. Article
  4. Article
  5. Human Immune System Reconstitution in NOD/Shi-Life (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jianshui ZhangSchool of Biological Sciences, University of Nebraska-Lincoln, NE, United States.
Saroj Chandra LohaniSchool of Biological Sciences, University of Nebraska-Lincoln, NE, United States.
Yilun ChengSchool of Biological Sciences, University of Nebraska-Lincoln, NE, United States.
Tao WangSchool of Biological Sciences, University of Nebraska-Lincoln, NE, United States.
Lili GuoDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Woong-Ki KimDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA, United States.
Santhi GorantlaDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, United States.
Qingsheng LiSchool of Biological Sciences, University of Nebraska-Lincoln, NE, United States.
University of Nebraska–Lincoln · USUniversity of Nebraska Medical Center · USEastern Virginia Medical School · US

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 ReservoirR01AI136756 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LI, QINGSHENG, LI, YUXING · 2019 to 2023
$3.9M
Anti-flavivirus B cell response analysis to aid vaccine designR01AI175439 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Yuxing Li · 2023 to 2026
$3.1M
Impact of the gut microbiome on HIV-1 rectal transmission and immunopathogenesis during ARTR21AI143405 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI LI, QINGSHENG · 2019 to 2020
$417k
NIAID NIH HHS R01 AI136756NIAID NIH HHS R01 AI175439NIAID NIH HHS R21 AI143405NIMH NIH HHS P30 MH062261
6 · The paper itself

Abstract

Humanized bone marrow-liver-thymic (hu-BLT) mice develop a functional immune system in periphery, nevertheless, have a limited reconstitution of human myeloid cells, especially microglia, in CNS. Further, whether bone marrow derived hematopoietic stem and progenitor cells (HSPCs) can enter the brain and differentiate into microglia in adults remains controversial. To close these gaps, in this study we unambiguously demonstrated that human microglia in CNS were extensively reconstituted in adult NOG mice with human interleukin-34 transgene (hIL34 Tg) from circulating CD34+ HSPCs, nonetheless not in hu-BLT NOG mice, providing strong evidence that human CD34+ HSPCs can enter adult brain and differentiate into microglia in CNS in the presence of hIL34. Further, the human microglia in the CNS of hu-BLT-hIL34 NOG mice robustly supported HIV-1 infection reenforcing the notion that microglia are the most important target cells of HIV-1 in CNS and demonstrating its great potential as an

Indexed as

Disease Models, AnimalInterleukinsAnimalsBrainCell DifferentiationHematopoietic Stem Cell TransplantationHIV-1HIV InfectionsHumansMiceMice, TransgenicMicrogliaTransgenesIL34 protein, humanInterleukinsHIV-1Hu-BLT miceinterleukin-34microgliaNOG mice

Identifiers

PMID34093573
PMCPMC8176960
OpenAlexW3165675912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.